Increased muscle sympathetic nerve activity predicts mortality in heart failure patients

International Journal of Cardiology

Volumn 135, Issue 3, 2009, Pages 302-307

  Barretto, Antonio C P ^a   Santos, Amilton C ^a   Munhoz, Robinson ^a   Rondon, Maria U P B ^a   Franco, Fábio G ^a   Trombetta, Ivani C ^a   Roveda, Fabiana ^a   de Matos, Luciana N J ^a   Braga, Ana M W ^a   Middlekauff, Holly R ^b   Negrão, Carlos E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Forearm blood flow; Heart failure; Mortality rate; Muscle sympathetic nerve activity

Indexed keywords

ADULT; ARTICLE; FEMALE; FOREARM BLOOD FLOW; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE INNERVATION; MUSCLE SYMPATHETIC NERVE ACTIVITY; NERVE CONDUCTION; NEUROGRAPHY; PERONEUS MUSCLE; PERONEUS NERVE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SYMPATHETIC NERVE; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 67349168021     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.03.056     Document Type: Article

References (32)

1. Chidsey C.A., Harrison D.C., and Braunwald E. Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. N Engl J Med 267 (1962) 650-654
2. Francis G.S., Golsmith S.R., Levine T.B., Olivari M.T., and Cohn J.N. The neurohumoral axis in congestive heart failure. Ann Intern Med 101 (1984) 370-377
3. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
4. Levine T.B., Francis G.S., Goldsmith S.R., Simon A.B., and Cohn J.N. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49 (1982) 1659-1666
5. Thomas J.A., and Marks B.H. Plasma norepinephrine in congestive heart failure. Am J Cardiol 41 (1978) 233-243
6. Negrao C.E., Rondon M.U., Tinucci T., et al. Abnormal neurovascular control during exercise is linked to heart failure severity. Am J Physiol Heart Circ Physiol 280 (2001) H1286-H1292
7. Esler M., and Kaye D. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail Rev 5 (2000) 17-25
8. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 (1984) 819-823
9. Brouwer J., van Veldhuisen D.J., Man in 't Veld A.J., et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. J Am Coll Cardiol 28 (1996) 1183-1189
10. Kinugawa T., Ogino K., Osaki S., et al. Prognostic significance of exercise plasma noradrenaline levels for cardiac death in patients with mild heart failure. Circ J 66 (2002) 261-266
11. Davis D., Baily R., and Zelis R. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Am J Physiol 254 (1988) E760-E766
12. Hasking G.J., Esler M.D., Jennings G.L., Burton D., Johns J.A., and Korner P.I. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73 (1986) 615-621
13. Wallin B.G., Delius W., and Sundlof G. Human muscle nerve sympathetic activity in cardiac arrhythmias. Scand J Clin Lab Invest 34 (1974) 293-300
14. Vanhoutte P.M. Adjustments in the peripheral circulation in chronic heart failure. Eur Heart J 4 (1983) 67-83
15. Zelis R., Mason D.T., and Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 47 (1968) 960-970
16. Zelis R., and Flaim S.F. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovascular Dis 24 (1982) 437-459
17. Middlekauff H.R., Nitzsche E.U., Nguyen A.H., Hoh C.K., and Gibbs G.G. Modulation of renal cortical blood flow during static exercise in humans. Circ Res 80 (1997) 62-68
18. Heitzer T., Baldus S., von Kodolitsch Y., Rudolph V., and Meinertz T. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure. Arterioscler Thromb Vasc Biol 25 (2005) 1174-1179
19. Fischer D., Rossa S., Landmesser U., et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26 (2005) 65-69
20. Delius W., Hagbarth K.E., Hongell A., and Wallin B.G. Maneuvers affecting sympathetic outflow in human muscle nerves. Acta Physiol Scand 84 (1972) 82-94
21. Vallbo A.B., Hagbarth K.E., Torebjork H.E., and Wallin B.G. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev 59 (1979) 919-957
22. Santos A.C., Alves M.J., Rondon M.U., Barretto A.C., Middlekauff H.R., and Negrao C.E. Sympathetic activation restrains endothelium-mediated muscle vasodilatation in heart failure patients. Am J Physiol Heart Circ Physiol 289 (2005) H593-H599
23. Katz S.D., Hryniewicz K., Hriljac I., et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111 (2005) 310-314
24. Neglia D., Michelassi C., Trivieri M.G., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105 (2002) 186-193
25. Krizanac-Bengez L., Mayberg M.R., Cunningham E., et al. Loss of shear stress induces leukocyte-mediated cytokine release and blood-brain barrier failure in dynamic in vitro blood-brain barrier model. J Cell Physiol 206 (2006) 68-77
26. von Haehling S., Genth-Zotz S., Anker S.D., and Volk H.D. Cachexia: a therapeutic approach beyond cytokine antagonism. Int J Cardiol 85 (2002) 173-183
27. Anker S.D., Swan J.W., Volterrani M., et al. The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. Eur Heart J 18 (1997) 259-269
28. Piepoli M.F., Kaczmarek A., Francis D.P., et al. Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure. Circulation 114 (2006) 126-134
29. Adamopoulos S., Parissis J., Karatzas D., et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol 39 (2002) 653-663
30. Caulin-Glaser T., Falko J., Hindman L., La Londe M., and Snow R. Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease. J Cardiopulm Rehabil 25 (2005) 332-336
31. Gielen S., Adams V., Mobius-Winkler S., et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 42 (2003) 869-872
32. Hambrecht R., Schulze P.C., Gielen S., et al. Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 12 (2005) 401-406